Pattern Bioscience, Inc.
Austin, TX
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- Great Hills Plaza, 9600 Great Hills Trail #160E, Austin, TX 78759, USA
- Website
- pattern.bio
- Founded
- 2016
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $22,500,000 |
Contract awards
Similar vendors
About the company
Pattern Bioscience, Inc. is a biotechnology company located in Austin, Texas, specializing in developing advanced diagnostic platforms for rapid pathogen identification and antimicrobial susceptibility testing. Registered in SAM.gov since July 2017, the company operates as a for-profit organization and manufacturer of goods, with a focus on creating innovative medical diagnostic technologies that can significantly improve clinical treatment strategies.
Through federal contract awards, Pattern Bioscience has been engaged in developing a cutting-edge diagnostic platform in collaboration with the Office of the Assistant Secretary for Preparedness and Response (ASPR) and the Biomedical Advanced Research and Development Authority (BARDA). Their primary contract, valued at $40,937,536.73, involves verification, clinical evaluation, and FDA clearance of a culture-free, phenotypic diagnostic platform designed to rapidly identify pathogens and determine antimicrobial susceptibility. The contract, awarded on September 26, 2024, with an ultimate completion date of January 31, 2029, is a definitive cost-sharing agreement. The prime contractor for this work is the Trustees of Boston University, with Pattern Bioscience functioning as a subcontractor. There was no specific set-aside designation for this contract award.
In terms of federal grant awards, Pattern Bioscience has continued its work on developing a single cell analysis platform through sub-awards from the Trustees of Boston University. These grants focus on creating a diagnostic technology that enables fast, targeted antibiotic treatment by delivering rapid pathogen identification and phenotypic antimicrobial susceptibility test results. The platform aims to reduce system complexity, enable cost-effective testing, and permit testing directly from challenging non-sterile specimens. By developing a method that can dramatically shorten the empiric treatment time window, the company seeks to improve patient outcomes and help preserve the efficacy of critical antibiotics. The grant sub-awards, dated March 25, 2022, and August 6, 2021, further support the company's innovative approach to addressing clinical challenges in pathogen identification and antibiotic treatment.
Quick answers
Is Pattern Bioscience, Inc. registered in SAM.gov?
Yes. Pattern Bioscience, Inc.'s SAM.gov registration is active through March 24, 2027.
What is Pattern Bioscience, Inc.'s CAGE code?
Pattern Bioscience, Inc.'s CAGE code is 7WHT1, and its Unique Entity ID (UEI) is KGNTWWVCEM33.
How much has Pattern Bioscience, Inc. received in federal contracts?
Federal contracts obligated $22,500,000 to Pattern Bioscience, Inc. in fiscal years 2023 through 2027.
What is Pattern Bioscience, Inc.'s most recent federal award?
Pattern Bioscience, Inc.'s most recent federal contract award is Verification, clinical evaluation, and FDA clearance of the world's first culture-free phenotypic ID/AST diagnostic… (75A50124C00042), from Office of the Assistant Secretary for Preparedness and Response, on September 26, 2024.
On GovTribe
See Pattern Bioscience, Inc.'s full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors